Published on
February 28, 2021
- 06:00 GMT
Development of microRNA-based TREATMENTS for MYOTONIC DYSTROPHY Type 1 by Translational Genomics Group
Dr. Artero’s Lab, based in Spain (University of Valencia), is a pioneer in discovering therapeutic targets and innovative drug candidates for rare diseases VALENCIA, VALENCIA, SPAIN, February 28, 2021 /EINPresswire.com/ -- Translational Genomics Group ( …
Distribution channels:
Banking, Finance & Investment Industry, Companies
...
